Top

Published in:

01-12-2012 | Letter to the Editors

Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism

Authors: Jürgen Leick, Christoph Liebetrau, Sebastian Szardien, Matthias Willmer, Johannes Rixe, Holger Nef, Andreas Rolf, Christian Hamm, Helge Möllmann

Published in: Clinical Research in Cardiology | Issue 12/2012

Excerpt

Sirs: …

Torbicki A, Perrier A, Konstantinides S, Agnelli G, ESC Committee for Practice Guidelines (CPG), Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 29:2276–2315PubMedCrossRef

Koenigshausen E, Magnusson K, Vester EG (2007) Successful thrombolysis in patient with right heart thromboembolism: a case report and literature overview. Clin Res Cardiol 96(10):755–758PubMedCrossRef

Sors H, Pacouret G, Azarian R et al (1994) Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 106:712–717PubMedCrossRef

Kasper W, Konstantinides S, Geibel A et al (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30:1165–1171PubMedCrossRef

Goldhaber S, Haire W, Feldstein M et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511PubMedCrossRef

Agnelli G, Becattini C, Kirschstein T et al (2002) Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med 162:2537–2541PubMedCrossRef

Dalla-Volta S, Palla A, Santolicandro A et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526PubMedCrossRef

Konstantinides S (2008) Clinical practice. Acute pulmonary embolism. N Engl J Med 359(26):2804–2813PubMedCrossRef

Lankeit M, Konstantinides S (2011) Mortality risk assessment and the role of thrombolysis in pulmonary embolism. Crit Care Clin 27(4):953–967PubMedCrossRef

10.

Stein P, Matta F, Steinberger D, Keyes D (2012) Intracerebral hemorrhage with thrombolytic therapy for acute pulmonary embolism. Am J Med 125(1):50–56PubMedCrossRef

11.

Laporte S, Mismetti P, Décousus H et al (2008) Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 117(13):1711–1716PubMedCrossRef

12.

Goldhaber S, Visani L, De Rosa M et al (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353(9162):1386–1389PubMedCrossRef

13.

Aujesky D, Obrosky D, Stone R et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046PubMedCrossRef

14.

Wicki J, Perrier A, Perneger T et al (2000) Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemostasis 84:548–552

15.

Berghaus T, von Scheidt W, Schwaiblmair M (2011) Time between first symptoms and diagnosis in patients with acute pulmonary embolism: are patients with recurrent episodes diagnosed earlier? Clin Res Cardiol 100(2):117–119PubMedCrossRef

16.

Stein P, Matta F (2012) Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 125(5):465–470PubMedCrossRef

17.

Zobel C, Dörpinghaus M, Reuter H et al (2012) Mortality in a cardiac intensive care unit. Clin Res Cardiol. doi:10.1007/s00392-012-0421-9

18.

Lam K, Sjauw K, Henriques J et al (2009) Improved microcirculation in patients with an acute ST-elevation myocardial infarction treated with the Impella LP2.5 percutaneous left ventricular assist device. Clin Res Cardiol 98(5):311–318PubMedCrossRef

19.

Ferrari M, Scholz K, Figulla H (1996) PTCA with the use of cardiac assist devices: risk stratification, short- and long-term results. Catheter Cardiovasc Diagn 38(3):242–248CrossRef

20.

Ferrari M, Hekmat K, Jung C et al (2011) Better outcome after cardiopulmonary resuscitation using percutaneous emergency circulatory support in non-coronary patients compared to those with myocardial infarction. Acute Card Care 13(1):30–34PubMedCrossRef

21.

Basic D, Möllmann H, Haas M et al (2012) A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation. Clin Res Cardiol 101(2):149–153PubMedCrossRef

22.

Cove M, MacLaren G (2010) Critical Care 14:235PubMedCrossRef

Title: Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism
Authors: Jürgen Leick
Christoph Liebetrau
Sebastian Szardien
Matthias Willmer
Johannes Rixe
Holger Nef
Andreas Rolf
Christian Hamm
Helge Möllmann
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Clinical Research in Cardiology / Issue 12/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-012-0481-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2012

Right ventricular hypertrophy after atrial switch operation: normal adaptation process or risk factor? A cardiac magnetic resonance study

Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access

Percutaneous edge-to-edge mitral valve repair for recurrent mitral regurgitation after percutaneous mitral annuloplasty: towards a staged approach

A prospective, randomized trial of continuous lateral rotation (“kinetic therapy”) in patients with cardiogenic shock

Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry

Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the “German chest pain unit registry”

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page